Cresco Labs (CRLBF) Common Equity (2019 - 2025)

Cresco Labs has reported Common Equity for 7 years, with the latest figure at $340.4 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 28.3% year-over-year to $340.4 million; the trailing twelve-month figure through Dec 2025 stood at $340.4 million (down 28.3% YoY), and the FY2025 full-year result was $340.4 million, down 28.3% from the prior year.
• Common Equity for Q4 2025 stood at $340.4 million, down from $474.9 million in the prior quarter.
• The five-year high for Common Equity was $755.6 million in Q4 2021, with the low at $340.4 million in Q4 2025.
• Historically, Common Equity has averaged $517.3 million across 5 years, with a median of $474.9 million in 2024.
• Annual changes were most pronounced in 2021 — Common Equity jumped 59.66% — and 2025, when it dropped 28.3%.
• Cresco Labs' Common Equity stood at $755.6 million in 2021, then retreated by 22.22% to $587.7 million in 2022, then declined by 27.16% to $428.1 million in 2023, then grew by 10.93% to $474.9 million in 2024, then declined by 28.3% to $340.4 million in 2025.
• The last three Common Equity figures came in at $340.4 million (Q4 2025), $474.9 million (Q4 2024), and $428.1 million (Q4 2023), per Business Quant data.